Latest Regulatory News

Halo Technologies Holdings has responded to ASX queries about a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with continuous disclosure rules.

The Federal Court of Australia has approved the acquisition of NSX Limited by a related entity of the Canadian Securities Exchange operator, setting the stage for NSX’s delisting from the ASX later this month.

Elevate Uranium Ltd has agreed to sell its Oobagooma Uranium Project to Orpheus Uranium Ltd in a deal combining cash and milestone-based equity payments, aligning with Elevate’s pivot towards its innovative U-pgrade beneficiation technology and other core assets.

Orpheus Uranium Limited has agreed to acquire the Oobagooma Uranium Project in Western Australia, unlocking significant historical uranium mineralisation and exploration potential in the Canning Basin.

Falcon Metals confirms exceptional high-grade gold intercepts at its Blue Moon project, extending the renowned Bendigo Goldfield. The company accelerates exploration with new drill pads and a second rig, backed by a strong cash position.

Aguia Resources has locked in a R$6 million (A$1.7 million) bank loan to advance its Tres Estradas phosphate mine in Brazil, aiming for over 160,000 tonnes annual production by 2027. Initial sales agreements and a strong market backdrop set the stage for a potentially lucrative operation.

Chariot Corporation confirms extensive lithium-bearing pegmatites at its Nigerian Fonlo and Iganna projects, setting the stage for small-scale mechanized mining and systematic exploration in 2026. Assay results and acquisition completion remain key near-term milestones.

Clarity Pharmaceuticals’ Co-PSMA Phase II trial shows its Cu-SAR-bisPSMA diagnostic agent detects more prostate cancer lesions than current standard imaging, promising earlier and more accurate recurrence detection.

Resouro Strategic Metals is on track to close its non-brokered private placement within the week, aiming to fund critical engineering work for its Tiros Titanium-Rare Earths Project in Brazil.

Titanium Sands Limited has locked in $800,000 in stage two funding to complete environmental studies and advance the Industrial Mining Licence for its Mannar Island Project in Sri Lanka, backed by strong government support.

Gryphon Capital Income Trust (ASX, GCI) has opened a non-underwritten unit purchase plan offering new units at A$2.00 each to eligible unitholders in Australia and New Zealand. The offer aims to raise up to A$337 million to support portfolio growth.

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.